This study is assessing the accuracy of continuous glucose monitors during surgical procedures requiring anesthesia.
Participants will be 2 to 26 years of age at the time of enrollment.
Participants will have a diagnosis of type 1 diabetes on insulin therapy and requiring close glucose monitoring during the hospitalization and the perioperative period.
Participant currently wearing a continuous glucose monitor (for example: Dexcom G6 or G7; Freestyle Libre 2, 2 Plus, or 3; Medtronic Guardian 3 or 4; or future sensors as they become available) for home diabetes management and willing to share personal CGM data with the BDC clinical CGM account.
Pregnancy.
Currently using hydroxyurea.
A condition that the investigator determines would prevent the patient from participation.
All participants will have a clinical diagnosis of type 1 diabetes and be wearing a continuous glucose monitor as part of routine care.
Cohort
Prospective
Not listed
Accuracy of CGM compared to blood glucose using standard statistical methods including mean absolute relative difference (MARD).
Accuracy assessment will be completed comparing CGM glucose values to blood glucose values using standard statistical assessments.
Click on the lead sponsor to view all of their trials.
